Cargando…
Antibodies in infectious diseases: polyclonals, monoclonals and niche biotechnology
Antibody preparations have a long history of providing protection from infectious diseases. Although antibodies remain the only natural host-derived defense mechanism capable of completely preventing infection, as products, they compete against inexpensive therapeutics such as antibiotics, small mol...
Autores principales: | Berry, Jody D., Gaudet, Ryan G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7185793/ https://www.ncbi.nlm.nih.gov/pubmed/21473942 http://dx.doi.org/10.1016/j.nbt.2011.03.018 |
Ejemplares similares
-
Uses and Challenges of Antiviral Polyclonal and Monoclonal Antibody Therapies
por: Struble, Evi B., et al.
Publicado: (2023) -
Passive Monoclonal and Polyclonal Antibody Therapies
por: Pelletier, J. Peter R., et al.
Publicado: (2020) -
Monoclonal and Polyclonal Antibodies Specific to Human Fibromodulin
por: Farahi, Lia, et al.
Publicado: (2019) -
Production and application of polyclonal and monoclonal antibodies against Spiroplasma eriocheiris
por: Zhang, Ying, et al.
Publicado: (2015) -
Mode of neutralization of lactate dehydrogenase-elevating virus by polyclonal and monoclonal antibodies
por: Plagemann, P. G. W., et al.
Publicado: (1992)